Showing results (241-250 of 1,408) with videos related to

Sort By:
Pageof 141
NPJ Parkinson'S Disease|August 1, 2024
Nigral ATP13A2 depletion induces Parkinson's disease-related neurodegeneration in a pilot study in non-human primatesJoanna Sikora, Sandra Dovero, Rémi Kinet, et al.
NPJ Parkinson'S Disease|August 16, 2024
MRI subtypes in Parkinson's disease across diverse populations and clustering approachesAnna Inguanzo, Rosaleena Mohanty, Konstantinos Poulakis, et al.
NPJ Parkinson'S Disease|July 31, 2024
Plasma biomarkers of neurodegeneration in patients and high risk subjects with Lewy body diseaseKeita Hiraga, Makoto Hattori, Yuki Satake, et al.
NPJ Parkinson'S Disease|August 15, 2024
CSF markers of neurodegeneration Alzheimer's and Lewy body pathology in isolated REM sleep behavior disorderAmaia Muñoz-Lopetegi, Simone Baiardi, Mircea Balasa, et al.
NPJ Parkinson'S Disease|July 1, 2024
Associations of cholinergic system integrity with cognitive decline in GBA1 and LRRK2 mutation carriersJulia Schumacher, Nicola Ray, Stefan Teipel, et al.
NPJ Parkinson'S Disease|July 1, 2024
Identification of metabolites reproducibly associated with Parkinson's Disease via meta-analysis and computational modellingXi Luo, Yanjun Liu, Alexander Balck, et al.
NPJ Parkinson'S Disease|July 19, 2024
Adult-onset deletion of ATP13A2 in mice induces progressive nigrostriatal pathway dopaminergic degeneration and lysosomal abnormalitiesMadalynn L Erb, Kayla Sipple, Nathan Levine, et al.
NPJ Parkinson'S Disease|June 15, 2024
Tau seeding activity in skin biopsy differentiates tauopathies from synucleinopathiesIlaria Linda Dellarole, Elena Vacchi, Inigo Ruiz-Barrio, et al.
NPJ Parkinson'S Disease|November 3, 2023
Overview on wearable sensors for the management of Parkinson's diseaseCaroline Moreau, Tiphaine Rouaud, David Grabli, et al.
NPJ Parkinson'S Disease|October 31, 2023
Characterization of the pathogenic α-Synuclein Variant V15A in Parkinson´s diseaseSokhna Haissatou Diaw, Max Borsche, Linn Streubel-Gallasch, et al.
Pageof 141